Adeka (4401) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Mar, 2026Executive summary
FY2024 saw record highs in net sales (¥407.1B), operating profit (¥41.0B), and net profit per share (¥245.6), despite global economic uncertainty and regional slowdowns.
Overseas sales ratio increased to 54.9%, reflecting strong global expansion.
Growth was driven by strong performance in Chemicals, especially Polymer Additives, Electronic Materials, and Environmental Materials, while Food Products and Life Science saw decreased sales but improved profitability.
Progress continued on the MTMP ADX 2026 plan, focusing on profitability, sustainability, and global growth.
Financial highlights
Net sales rose 1.8% year-over-year to ¥407.1B; operating profit up 15.8% to ¥41.0B; ordinary profit up 10.0% to ¥39.3B; net profit per share up 8.9% to ¥245.6.
Cash and deposits grew by ¥11.6B; cash and cash equivalents at year-end increased by 11.2% to ¥107.8B.
Dividend per share increased to ¥100 in FY2024, with a forecast of ¥104 for FY2025.
Comprehensive income declined to ¥25.4B from ¥39.2B due to negative foreign currency translation adjustments.
Outlook and guidance
FY2025 net sales forecast at ¥441.0B (+8.3%), operating profit at ¥43.0B (+4.9%), and profit attributable to owners of parent to grow 5.5% to ¥26.4B.
Net profit per share projected at ¥259.5; dividend payout ratio to remain above 40%.
Market environment expected to remain resilient but with uncertainties from U.S. tariffs and material price volatility; impact of U.S. tariff policy not included in forecasts.
Latest events from Adeka
- Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 202610 Mar 2026 - Life Science strength drove profit growth, offsetting Chemicals and Food Products weakness.4401
Q2 202610 Mar 2026 - Profits and sales grew, led by Chemicals and Food Products, with raised outlook and Life Science loss.4401
Q1 202510 Mar 2026 - Strategic investments and innovation in semiconductor materials target rapid global growth.4401
Investor presentation10 Mar 2026 - 3Q FY2024 saw higher sales and profits, driven by Chemicals and global expansion.4401
Q3 202510 Mar 2026 - Strong 1H FY2024 results and Chemicals growth led to higher guidance and dividend forecasts.4401
Q2 202510 Mar 2026 - Profit rose on strong Life Science and Environmental Materials, offsetting Chemicals weakness.4401
Q3 202610 Mar 2026